FDA gains power to block food additives; manufacturers must prove safety first
H.R. 4958 — GRAS Act · Filed by Frank Pallone (D-NJ) · 5 cosponsors · Introduced Aug 12, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill removes the automatic exemption that food additives have from FDA pre-market review if they are 'generally recognized as safe' (GRAS). Instead, manufacturers must notify the FDA before using any new GRAS substance or any substance not marketed in U.S. foods before enactment, provide detailed safety data, and wait for FDA approval before marketing. The FDA must also systematically reassess the safety of at least 10 existing GRAS substances every 3 years and can revoke prior approvals if new evidence emerges. Manufacturers and petitioners pay fees to fund these reviews.
Why we flagged it
The bill's core mechanism is to eliminate a regulatory exemption and impose pre-market notification and periodic reassessment requirements on food additives. This is a straightforward expansion of FDA authority and consumer protection, not a carve-out or subsidy.
What the text implies
- The 180-day (plus optional 90-day extension) review timeline may create bottlenecks if FDA lacks resources, potentially delaying new food products and innovation, though the bill authorizes appropriations to address this.
- Manufacturers may face significant compliance costs gathering and submitting detailed safety data, which could be passed to consumers through higher food prices, particularly for smaller food companies with fewer resources.
The full analysis lists 5 implications of this text.
Who stands to gain
FDA (increased appropriations and fee revenue); Contract research organizations and toxicology labs (hired to conduct reassessments); Regulatory consultants and food safety compliance firms